Name: Faecalibacterium duncaniae A2-165
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 17680

Type strain:

Species: Faecalibacterium duncaniae

Strain Designation: A2-165

Culture col. no.: DSM 17677, JCM 31915

Strain history: DSM 17677 <-- S. Duncan; A2-165 <-- A. Barcenilla.

NCBI tax ID(s): 853 (species)

SI-ID 297647

DSM 17677, VTT E-093116

Section

Faecalibacterium duncaniae A2-165 is an anaerobe, mesophilic bacterium that was isolated from human, female, 34 years, faecal sample.

anaerobe
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Clostridia*
	Order	*Eubacteriales*
	Family	*Oscillospiraceae*
	Genus	*Faecalibacterium*
	Species	**Faecalibacterium duncaniae**
	Full Scientific Name (LPSN)	Faecalibacterium duncaniae Sakamoto et al. 2022

Synonym

Faecalibacterium hominis

Information on morphological and physiological properties Morphology

[Ref.: #69480]	Gram stain	positive Confidence in %100

[Ref.: #69480]	Motility	no Confidence in %90.209

Information on culture and growth conditions Culture and growth conditions

[Ref.: #7119]

Culture medium

YCFA-MEDIUM (MODIFIED) (DSMZ Medium 1611)

[Ref.: #7119]

Culture medium growth

[Ref.: #7119]

Culture medium link

Medium recipe at MediaDive

[Ref.: #7119]

Culture medium composition

expand / minimize

	Temperatures	Kind of temperature		Temperature
[Ref.: #7119]			growth	37 °C
[Ref.: #67770]			growth	37 °C

[Ref.: #7119]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #7119]	Oxygen tolerance	anaerobe
[Ref.: #69480]	Oxygen tolerance	anaerobe Confidence in %99.998

[Ref.: #69481]	Ability of spore formation	no Confidence in %100
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.916

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68380]	D-mannose ChEBI	-	fermentation	* from API rID32A
[Ref.: #68380]	nitrate ChEBI	-	reduction	* from API rID32A
[Ref.: #68380]	tryptophan ChEBI	-	energy source	* from API rID32A
[Ref.: #68380]	urea ChEBI	-	hydrolysis	* from API rID32A

	Metabolite production	Metabolite	Production
[Ref.: #68380]		indole ChEBI	no	* from API rID32A

	Physiological tests	Metabolite	Indole test
[Ref.: #68380]		indole ChEBI	-	* from API rID32A

	Enzyme	Enzyme activity	EC number
[Ref.: #68380]	alanine arylamidase	-	3.4.11.2	* from API rID32A
[Ref.: #68380]	alkaline phosphatase	-	3.1.3.1	* from API rID32A
[Ref.: #68380]	alpha-arabinosidase	-	3.2.1.55	* from API rID32A
[Ref.: #68380]	alpha-fucosidase	-	3.2.1.51	* from API rID32A
[Ref.: #68380]	beta-galactosidase	+	3.2.1.23	* from API rID32A
[Ref.: #68380]	beta-glucosidase	-	3.2.1.21	* from API rID32A
[Ref.: #68380]	beta-glucuronidase	+	3.2.1.31	* from API rID32A
[Ref.: #68380]	glutamyl-glutamate arylamidase	-		* from API rID32A
[Ref.: #68380]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API rID32A
[Ref.: #68380]	phenylalanine arylamidase	-		* from API rID32A
[Ref.: #68380]	proline-arylamidase	-	3.4.11.5	* from API rID32A
[Ref.: #68380]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API rID32A
[Ref.: #68380]	serine arylamidase	-		* from API rID32A
[Ref.: #68380]	tryptophan deaminase	-	4.1.99.1	* from API rID32A
[Ref.: #68380]	tyrosine arylamidase	-		* from API rID32A
[Ref.: #68380]	urease	-	3.5.1.5	* from API rID32A
	Only first 10 entries are displayed. Click here to see all.

API® rID32A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	alpha-Galactosidasealpha GAL	beta-Galactosidasebeta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha-Glucosidasealpha GLU	beta-Glucosidasebeta GLU	alpha-Arabinosidasealpha ARA	beta-Glucuronidasebeta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	Fermentation of D-mannoseMNE	Fermentation of raffinoseRAF	Glutamate decarboxylaseGDC	alpha-Fucosidasealpha FUC	Reduction of nitrateNIT	Indole productionIND	Alkaline phosphatasePAL	L-arginine arylamidaseArgA	Proline arylamidaseProA	Leucyl glycin arylamidaseLGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	Pyrrolidonyl arylamidasePyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
[Ref.: #7119]	13175	-	-	-	+	+	+	-	-	+	-	-	-	-	-	-	-	-	+	-	+	-	-	-	-	-	+	+	-	-
[Ref.: #7119]	12659	-	-	+/-	+	+	+	-	-	+	-	-	-	-	-	-	-	-	+	-	+	-	+	-	-	-	+	+	-	-
[Ref.: #7119]	12660	-	+	-	+	-	-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #7119]	12661	-	-	+/-	+	+	+/-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #7119]	12662	-	-	-	+	+	+	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	+/-	+/-	-	-
[Ref.: #7119]	12663	-	+	-	+	-	-	-	-	+	-	-	-	+	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #7119]	12664	-	-	-	+	-	-	-	-	+	-	-	-	-	-	-	-	-	+/-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #7119]	12665	-	-	-	+	+/-	+/-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	+/-	-	-	-
[Ref.: #7119]	12666	-	-	-	+	-	+/-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #7119]	13015	-	-	-	+	+	+/-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	+/-	-	-	-
[Ref.: #7119]	13111	-	-	-	+	+/-	+/-	-	-	+	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	+	+/-	-	-
[Ref.: #7119]	12658	-	-	-	+	-	+	-	-	+	-	-	+	-	-	-	-	-	+	-	-	-	-	-	-	-	+/-	-	-	-

	Pathway	Enzyme coverage	Annotated reactions
	Pathway annotation	Computationally determined by
[Ref.: #66794]	C4 and CAM-carbon fixation	100	8 of 8
[Ref.: #66794]	starch degradation	100	10 of 10
[Ref.: #66794]	adipate degradation	100	2 of 2
[Ref.: #66794]	L-lactaldehyde degradation	100	3 of 3
[Ref.: #66794]	cis-vaccenate biosynthesis	100	2 of 2
[Ref.: #66794]	gluconeogenesis	100	8 of 8
[Ref.: #66794]	formaldehyde oxidation	100	3 of 3
[Ref.: #66794]	coenzyme A metabolism	100	4 of 4
[Ref.: #66794]	anapleurotic synthesis of oxalacetate	100	1 of 1
[Ref.: #66794]	folate polyglutamylation	100	1 of 1
[Ref.: #66794]	UDP-GlcNAc biosynthesis	100	3 of 3
[Ref.: #66794]	CDP-diacylglycerol biosynthesis	100	2 of 2
[Ref.: #66794]	vitamin B1 metabolism	92.31	12 of 13
[Ref.: #66794]	palmitate biosynthesis	90.91	20 of 22
[Ref.: #66794]	threonine metabolism	90	9 of 10
[Ref.: #66794]	CO2 fixation in Crenarchaeota	88.89	8 of 9
[Ref.: #66794]	chorismate metabolism	88.89	8 of 9
[Ref.: #66794]	aspartate and asparagine metabolism	88.89	8 of 9
[Ref.: #66794]	glycolate and glyoxylate degradation	83.33	5 of 6
[Ref.: #66794]	metabolism of amino sugars and derivatives	80	4 of 5
[Ref.: #66794]	peptidoglycan biosynthesis	80	12 of 15
[Ref.: #66794]	Entner Doudoroff pathway	80	8 of 10
[Ref.: #66794]	photosynthesis	78.57	11 of 14
[Ref.: #66794]	valine metabolism	77.78	7 of 9
[Ref.: #66794]	serine metabolism	77.78	7 of 9
[Ref.: #66794]	phenylalanine metabolism	76.92	10 of 13
[Ref.: #66794]	glycolysis	76.47	13 of 17
[Ref.: #66794]	lactate fermentation	75	3 of 4
[Ref.: #66794]	CMP-KDO biosynthesis	75	3 of 4
[Ref.: #66794]	acetate fermentation	75	3 of 4
[Ref.: #66794]	butanoate fermentation	75	3 of 4
[Ref.: #66794]	glycogen biosynthesis	75	3 of 4
[Ref.: #66794]	ppGpp biosynthesis	75	3 of 4
[Ref.: #66794]	sulfopterin metabolism	75	3 of 4
[Ref.: #66794]	NAD metabolism	72.22	13 of 18
[Ref.: #66794]	purine metabolism	69.15	65 of 94
[Ref.: #66794]	vitamin B12 metabolism	67.65	23 of 34
[Ref.: #66794]	molybdenum cofactor biosynthesis	66.67	6 of 9
[Ref.: #66794]	acetoin degradation	66.67	2 of 3
[Ref.: #66794]	pyrimidine metabolism	66.67	30 of 45
[Ref.: #66794]	methane metabolism	66.67	2 of 3
[Ref.: #66794]	d-xylose degradation	63.64	7 of 11
[Ref.: #66794]	isoleucine metabolism	62.5	5 of 8
[Ref.: #66794]	degradation of sugar alcohols	62.5	10 of 16
[Ref.: #66794]	ketogluconate metabolism	62.5	5 of 8
[Ref.: #66794]	glycogen metabolism	60	3 of 5
[Ref.: #66794]	hydrogen production	60	3 of 5
[Ref.: #66794]	histidine metabolism	58.62	17 of 29
[Ref.: #66794]	oxidative phosphorylation	58.24	53 of 91
[Ref.: #66794]	methionine metabolism	57.69	15 of 26
[Ref.: #66794]	propanol degradation	57.14	4 of 7
[Ref.: #66794]	reductive acetyl coenzyme A pathway	57.14	4 of 7
[Ref.: #66794]	glutamate and glutamine metabolism	57.14	16 of 28
[Ref.: #66794]	polyamine pathway	56.52	13 of 23
[Ref.: #66794]	alanine metabolism	55.17	16 of 29
[Ref.: #66794]	metabolism of disaccharids	54.55	6 of 11
[Ref.: #66794]	degradation of sugar acids	52	13 of 25
[Ref.: #66794]	phenylmercury acetate degradation	50	1 of 2
[Ref.: #66794]	mannosylglycerate biosynthesis	50	1 of 2
[Ref.: #66794]	ethanol fermentation	50	1 of 2
[Ref.: #66794]	dTDPLrhamnose biosynthesis	50	4 of 8
[Ref.: #66794]	6-hydroxymethyl-dihydropterin diphosphate biosynthesis	50	4 of 8
[Ref.: #66794]	aminopropanol phosphate biosynthesis	50	1 of 2
[Ref.: #66794]	suberin monomers biosynthesis	50	1 of 2
[Ref.: #66794]	ribulose monophosphate pathway	50	1 of 2
[Ref.: #66794]	arginine metabolism	50	12 of 24
[Ref.: #66794]	selenocysteine biosynthesis	50	3 of 6
[Ref.: #66794]	cysteine metabolism	50	9 of 18
[Ref.: #66794]	lipid metabolism	48.39	15 of 31
[Ref.: #66794]	non-pathway related	47.37	18 of 38
[Ref.: #66794]	leucine metabolism	46.15	6 of 13
[Ref.: #66794]	pentose phosphate pathway	45.45	5 of 11
[Ref.: #66794]	vitamin B6 metabolism	45.45	5 of 11
[Ref.: #66794]	proline metabolism	45.45	5 of 11
[Ref.: #66794]	d-mannose degradation	44.44	4 of 9
[Ref.: #66794]	cardiolipin biosynthesis	42.86	3 of 7
[Ref.: #66794]	heme metabolism	42.86	6 of 14
[Ref.: #66794]	lysine metabolism	42.86	18 of 42
[Ref.: #66794]	ubiquinone biosynthesis	42.86	3 of 7
[Ref.: #66794]	citric acid cycle	42.86	6 of 14
[Ref.: #66794]	tetrahydrofolate metabolism	42.86	6 of 14
[Ref.: #66794]	tyrosine metabolism	42.86	6 of 14
[Ref.: #66794]	ascorbate metabolism	40.91	9 of 22
[Ref.: #66794]	methylglyoxal degradation	40	2 of 5
[Ref.: #66794]	arachidonate biosynthesis	40	2 of 5
[Ref.: #66794]	O-antigen biosynthesis	40	2 of 5
[Ref.: #66794]	myo-inositol biosynthesis	40	4 of 10
[Ref.: #66794]	propionate fermentation	40	4 of 10
[Ref.: #66794]	tryptophan metabolism	39.47	15 of 38
[Ref.: #66794]	degradation of pentoses	39.29	11 of 28
[Ref.: #66794]	urea cycle	38.46	5 of 13
[Ref.: #66794]	isoprenoid biosynthesis	38.46	10 of 26
[Ref.: #66794]	cyanate degradation	33.33	1 of 3
[Ref.: #66794]	enterobactin biosynthesis	33.33	1 of 3
[Ref.: #66794]	lipid A biosynthesis	33.33	3 of 9
[Ref.: #66794]	nitrate assimilation	33.33	3 of 9
[Ref.: #66794]	degradation of hexoses	33.33	6 of 18
[Ref.: #66794]	IAA biosynthesis	33.33	1 of 3
[Ref.: #66794]	flavin biosynthesis	33.33	5 of 15
[Ref.: #66794]	octane oxidation	33.33	1 of 3
[Ref.: #66794]	glycine metabolism	30	3 of 10
[Ref.: #66794]	benzoyl-CoA degradation	28.57	2 of 7
[Ref.: #66794]	biotin biosynthesis	25	1 of 4
[Ref.: #66794]	cyclohexanol degradation	25	1 of 4
[Ref.: #66794]	degradation of aromatic, nitrogen containing compounds	25	3 of 12
[Ref.: #66794]	sulfate reduction	23.08	3 of 13
[Ref.: #66794]	4-hydroxymandelate degradation	22.22	2 of 9
[Ref.: #66794]	glutathione metabolism	21.43	3 of 14
		Only first 10 entries are displayed. Click here to see all.

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #7119]	Sample type/isolated from	human, female, 34 years, faecal sample
[Ref.: #7119]	Geographic location (country and/or sea, region)	United Kingdom
[Ref.: #7119]	Country	United Kingdom
[Ref.: #7119]	Country ISO 3 Code	GBR
[Ref.: #7119]	Continent	Europe
[Ref.: #7119]	Geographic location	56.0000°/-4.0000°

[Ref.: #67770]	Sample type/isolated from	Human feces
* marker position based on {}

Isolation sources categories

#Host	#Human	-
#Host Body Product	#Gastrointestinal tract	#Feces (Stool)

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence AJ270469 (>99% sequence identity) for Faecalibacterium from Microbeatlas

Aquatic Samples	44
Soil Samples	21
Animal Samples	3588
Plant Samples	1
Total Samples	3654

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #7119]

Biosafety level

Risk group (German classification)
According to TRBA 466

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Butyrate-producing bacterium A2-165 16S rRNA gene	AJ270469	1466	ENA	411483 tax ID

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Faecalibacterium duncaniae JCM 31915	GCA_010509575	complete	GenBank	411483 tax ID	*
[Ref.: #66792]	Faecalibacterium duncaniae A2-165	GCA_000162015	scaffold	GenBank	411483 tax ID	*
[Ref.: #66792]	Faecalibacterium prausnitzii A2-165	411483.3	wgs	PATRIC	411483 tax ID	*
[Ref.: #66792]	Faecalibacterium prausnitzii strain JCM31915 strain JCM 31915	853.7536	complete	PATRIC	853 tax ID	*
[Ref.: #66792]	Faecalibacterium prausnitzii A2-165	645951831	draft	JGI IMG/M	411483 tax ID	*

[Ref.: #67770]

GC-content

49 mol%

thermal denaturation, midpoint method (Tm)

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Faecalibacterium prausnitzii strain JCM31915 strain JCM 31915 PATRIC: 853.7536
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Faecalibacterium prausnitzii A2-165 JCM 31915 NCBI: GCA_010509575.1
[Ref.: #69480]	motile	no	91.776	no
[Ref.: #69480]	flagellated	no	97.283	no
[Ref.: #69480]	gram-positive	yes	84.582	no
[Ref.: #69480]	anaerobic	yes	99.628	no
[Ref.: #69480]	aerobic	no	98.76	no
[Ref.: #69480]	halophile	no	84.661	no
[Ref.: #69480]	spore-forming	no	89.232	no
[Ref.: #69480]	thermophile	no	97.915	no
[Ref.: #69480]	glucose-util	yes	88.866	no
[Ref.: #69480]	glucose-ferment	yes	79.384	no

Availability in culture collections External links

[Ref.: #7119]

Culture collection no.

DSM 17677, JCM 31915

[Ref.: #86671]

SI-ID 297647

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Metabolism	Vitamin Biosynthesis by Human Gut Butyrate-Producing Bacteria and Cross-Feeding in Synthetic Microbial Communities.	Soto-Martin EC, Warnke I, Farquharson FM, Christodoulou M, Horgan G, Derrien M, Faurie JM, Flint HJ, Duncan SH, Louis P	mBio	10.1128/mBio.00886-20	2020	*
Pathogenicity	Exopolysaccharides Produced by Lactobacillus rhamnosus KL 53A and Lactobacillus casei Fyos Affect Their Adhesion to Enterocytes.	Konieczna C, Slodzinski M, Schmidt MT	Pol J Microbiol	10.21307/pjm-2018-032	2018	*
Metabolism	Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community.	D'hoe K, Vet S, Faust K, Moens F, Falony G, Gonze D, Llorens-Rico V, Gelens L, Danckaert J, De Vuyst L, Raes J	Elife	10.7554/eLife.37090	2018	*
Metabolism	Enterococcus faecalis AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells.	O Cuiv P, Giri R, Hoedt EC, McGuckin MA, Begun J, Morrison M	Front Immunol	10.3389/fimmu.2018.00790	2018	*
Phylogeny	Age and fecal microbial strain-specific differences in patients with spondyloarthritis.	Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, Danila MI, Spencer CH, Punaro MG, Schikler K, Reiff A, Kumar R, Cron RQ, Morrow CD, Lefkowitz EJ	Arthritis Res Ther	10.1186/s13075-018-1510-6	2018	*
Metabolism	Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes.	Moens F, De Vuyst L	Benef Microbes	10.3920/BM2016.0142	2017	*
Pathogenicity	Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function.	Ottman N, Reunanen J, Meijerink M, Pietila TE, Kainulainen V, Klievink J, Huuskonen L, Aalvink S, Skurnik M, Boeren S, Satokari R, Mercenier A, Palva A, Smidt H, de Vos WM, Belzer C	PLoS One	10.1371/journal.pone.0173004	2017	*
Metabolism	Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii.	Moens F, Weckx S, De Vuyst L	Int J Food Microbiol	10.1016/j.ijfoodmicro.2016.05.015	2016	*
Metabolism	Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.	Rossi O, van Berkel LA, Chain F, Tanweer Khan M, Taverne N, Sokol H, Duncan SH, Flint HJ, Harmsen HJ, Langella P, Samsom JN, Wells JM	Sci Rep	10.1038/srep18507	2016	*
Metabolism	Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.	Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG	FEMS Microbiol Lett	10.1093/femsle/fnv176	2015	*
Metabolism	The microbiota shifts the iron sensing of intestinal cells.	Deschemin JC, Noordine ML, Remot A, Willemetz A, Afif C, Canonne-Hergaux F, Langella P, Karim Z, Vaulont S, Thomas M, Nicolas G	FASEB J	10.1096/fj.15-276840	2015	*
Metabolism	Hydrodynamic chronoamperometry for probing kinetics of anaerobic microbial metabolism--case study of Faecalibacterium prausnitzii.	Prevoteau A, Geirnaert A, Arends JBA, Lannebere S, Van de Wiele T, Rabaey K	Sci Rep	10.1038/srep11484	2015	*
Pathogenicity	Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.	Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclee de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JE, Bermudez-Humaran LG, Smokvina T, Langella P	Gut Microbes	10.4161/19490976.2014.990784	2015	*
Genetics	Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction.	El-Semman IE, Karlsson FH, Shoaie S, Nookaew I, Soliman TH, Nielsen J	BMC Syst Biol	10.1186/1752-0509-8-41	2014	*
Phylogeny	Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov.	Duncan SH, Hold GL, Harmsen HJM, Stewart CS, Flint HJ	Int J Syst Evol Microbiol	10.1099/00207713-52-6-2141	2002	*
Phylogeny	Genome-based, phenotypic and chemotaxonomic classification of Faecalibacterium strains: proposal of three novel species Faecalibacterium duncaniae sp. nov., Faecalibacterium hattorii sp. nov. and Faecalibacterium gallinarum sp. nov.	Sakamoto M, Sakurai N, Tanno H, Iino T, Ohkuma M, Endo A	Int J Syst Evol Microbiol	10.1099/ijsem.0.005379	2022	*
Genetics	Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii.	Auger S, Kropp C, Borras-Nogues E, Chanput W, Andre-Leroux G, Gitton-Quent O, Benevides L, Breyner N, Azevedo V, Langella P, Chatel JM	Int J Mol Sci	10.3390/ijms23031705	2022	*
Cultivation	Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions.	Bellais S, Nehlich M, Ania M, Duquenoy A, Mazier W, van den Engh G, Baijer J, Treichel NS, Clavel T, Belotserkovsky I, Thomas V	Microbiome	10.1186/s40168-021-01206-7	2022	*
Phylogeny	Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677.	Machado D, Barbosa JC, Domingos M, Almeida D, Andrade JC, Freitas AC, Gomes AM	Int J Food Microbiol	10.1016/j.ijfoodmicro.2021.109501	2021	*
Pathogenicity	Functional dissection of the phosphotransferase system provides insight into the prevalence of Faecalibacterium prausnitzii in the host intestinal environment.	Kang D, Ham HI, Lee SH, Cho YJ, Kim YR, Yoon CK, Seok YJ	Environ Microbiol	10.1111/1462-2920.15681	2021	*
Metabolism	Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease.	Lapiere A, Geiger M, Robert V, Demarquay C, Auger S, Chadi S, Benadjaoud M, Fernandes G, Milliat F, Langella P, Benderitter M, Chatel JM, Semont A	Gut Microbes	10.1080/19490976.2020.1812867	2020	*
Phylogeny	On neotypes and nomina nova: commentary on "Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa", by C.B. Fitzgerald et al. (BMC Genomics (2018) 19:931).	Oren A, Garrity GM	BMC Genomics	10.1186/s12864-020-6680-3	2020	*
Phylogeny	Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa.	Fitzgerald CB, Shkoporov AN, Sutton TDS, Chaplin AV, Velayudhan V, Ross RP, Hill C	BMC Genomics	10.1186/s12864-018-5313-6	2018	*
Metabolism	Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.	Miquel S, Martin R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermudez-Humaran LG, Sokol H, Thomas M, Theodorou V, Langella P, Carvalho FA	Sci Rep	10.1038/srep19399	2016	*
Phylogeny	Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.	Song H, Yoo Y, Hwang J, Na YC, Kim HS	J Allergy Clin Immunol	10.1016/j.jaci.2015.08.021	2015	*
Metabolism	Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.	Rossi O, Khan MT, Schwarzer M, Hudcovic T, Srutkova D, Duncan SH, Stolte EH, Kozakova H, Flint HJ, Samsom JN, Harmsen HJ, Wells JM	PLoS One	10.1371/journal.pone.0123013	2015	*
Metabolism	Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.	Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermudez-Humaran LG, Sokol H, Thomas M, Langella P	mBio	10.1128/mBio.00300-15	2015	*
Pathogenicity	Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.	Martin R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermudez-Humaran LG	BMC Microbiol	10.1186/s12866-015-0400-1	2015	*
Metabolism	Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe.	Heinken A, Khan MT, Paglia G, Rodionov DA, Harmsen HJ, Thiele I	J Bacteriol	10.1128/JB.01780-14	2014	*
Metabolism	The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.	Martin R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermudez-Humaran LG, Langella P	Inflamm Bowel Dis	10.1097/01.MIB.0000440815.76627.64	2014	*
Pathogenicity	Faecalibacterium prausnitzii and human intestinal health.	Miquel S, Martin R, Rossi O, Bermudez-Humaran LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P	Curr Opin Microbiol	10.1016/j.mib.2013.06.003	2013	*
	Metabolic Response of Faecalibacterium prausnitzii to Cell-Free Supernatants from Lactic Acid Bacteria.	Lebas M, Garault P, Carrillo D, Codoner FM, Derrien M	Microorganisms	10.3390/microorganisms8101528	2020	*
	Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?	Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, Cole JA	FEMS Microbiol Lett	10.1111/j.1574-6968.2010.02057.x	2010	*

References

#7119

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 17677

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#66794

Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 )

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68380

Automatically annotated from API rID32A .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#86671

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID297647.1 )

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Faecalibacterium duncaniae in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Faecalibacterium prausnitzii strain JCM31915 strain JCM 31915

Faecalibacterium prausnitzii A2-165 JCM 31915

Change proposal

Change proposal